Synergistic targeting of malignant pleural mesothelioma cells by MDM2 inhibitors and TRAIL agonists

Malignant Pleural Mesothelioma (MPM) is a chemoresistant tumor characterized by low rate of p53 mutation and upregulation of Murine Double Minute 2 (MDM2), suggesting that it may be effectively targeted using MDM2 inhibitors. In the present study, we investigated the anticancer activity of the MDM2...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Urso, Loredana, Cavallari, Ilaria, Silic-Benussi, Micol, Biasini, Lorena, Zago, Giulia, Calabrese, Fiorella, Conte, Pier Franco, Ciminale, Vincenzo, Pasello, Giulia
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2017
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5546476/
https://ncbi.nlm.nih.gov/pubmed/28562336
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.17790
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados